What Are The Unmet Needs In ALS Research?In The Media
At AAN 2017, Merit Cudkowicz, MD, MSc., Chief of Neurology, Massachusetts General Hospital explained that ALS has changed dramatically in the last decade. "There's so much more hope and more knowledge about what might be happening," Cudkowicz told MD Magazine. She said that there are new foundations including the ALS Finding A Cure that aims to accelerate finding a cure. Also, according to Cudkowicz, the "Ice Bucket Challenge" really made a huge difference in awareness; people across the globe now know what ALS is.
MeiraGTx Awarded Target ALS Grant For Its NMD-Based Therapy for ALSIn The Media
MeiraGTx, a New York and UK based gene therapy company, announced today that it has been awarded a grant from Target ALS, a privately funded foundation bringing together a consortia of academic and biotech/pharmaceutical researchers focused on finding treatments for ALS patients. Target ALS is jointly funding this grant with the research organization ALS Finding A Cure®.
The ALS ONE Massachusetts ALS Partnership (MAP) Will Accelerate Treatment and Care in ALSIn The Media
The ALS Association today announced $2 million in funding to support ALS ONE-Massachusetts ALS Partnership (MAP), a partnership launched earlier this year among four institutional leaders in ALS treatment development: Massachusetts General Hospital (MGH), ALS Therapy Development Institute (ALS TDI), University of Massachusetts Medical School and Compassionate Care ALS (CCALS). The Association's contribution is in addition to $2 million from ALS Funding a Cure and $2 million from ALS ONE itself to support projects to help find treatments and a cure for amyotrophic lateral sclerosis (ALS).